ConductScience.org, home

Paper42007444

APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.

Mannelli F and 32 others. Hemasphere, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications. Papers, record 42007444. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007444

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.
PubMed
Journal
Hemasphere
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors33

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mannelli FFrancescohttps://orcid.org/0000-0003-4810-6501
2Crupi FFrancesca
3Bencini SSara
4Feuring MMichaela
5Ciolli GGaia
6Piccini MMatteo
7Frigeni MMarco
8Palmieri RRaffaele
9Sartor CChiara
10Scappini BBarbara
11Gianfaldoni GGiacomo
12Peruzzi BBenedetta
13Caporale RRoberto
14Scannella AAntonio
15Fasano LLaura
16Quinti EElisa
17Pasquini AAndrea
18Caroprese JJessica
19Signori LLeonardo
20Pancani FFabiana

Source PubMed

See all 33 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133047878Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy.Transfusion2021https://conductscience.org/library/papers/33047878PubMed
225528069Thrombotic events in acute promyelocytic leukemia.Thromb Res2015https://conductscience.org/library/papers/25528069PubMed
338831789Cup-like nuclei in adult B-cell acute lymphoblastic leukemia with the translocation (4;11)(q21;q23).Leuk Res Rep2024https://conductscience.org/library/papers/38831789PubMed
439457595Characteristics and Prognosis of "Acute Promyelocytic Leukemia-like" Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort.Biomedicines2024https://conductscience.org/library/papers/39457595PubMed
535081257Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.Blood Adv2022https://conductscience.org/library/papers/35081257PubMed
630563875Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.Blood2019https://conductscience.org/library/papers/30563875PubMed
740409258Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.Cell Stem Cell2025https://conductscience.org/library/papers/40409258PubMed
838387301The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.Thromb Res2024https://conductscience.org/library/papers/38387301PubMed
931698462Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.Blood Adv2019https://conductscience.org/library/papers/31698462PubMed
1031851556Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study.J Clin Oncol2020https://conductscience.org/library/papers/31851556PubMed
1136750485Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.Ann Hematol2023https://conductscience.org/library/papers/36750485PubMed
1230049734Cuplike nuclear morphology in pediatric B-cell acute lymphoblastic leukemia.Blood2018https://conductscience.org/library/papers/30049734PubMed
1329033137The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.Blood Rev2018https://conductscience.org/library/papers/29033137PubMed
1435797463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
1537187198Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.Lancet Haematol2023https://conductscience.org/library/papers/37187198PubMed
1639190465Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study.Blood2024https://conductscience.org/library/papers/39190465PubMed
177459811Reporting results of cancer treatment.Cancer1981https://conductscience.org/library/papers/7459811PubMed
1830803991Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.Blood2019https://conductscience.org/library/papers/30803991PubMed
1935732831The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732831PubMed
2027354723Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia.Blood2016https://conductscience.org/library/papers/27354723PubMed

See all 36 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42878784Thrombotic and hemorrhagic complications in NPM1-mutated AML: Association with APL-like immunophenotype and impact on early mortality.J Thromb Thrombolysis2026https://conductscience.org/library/papers/42878784

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
NPM14869PubTator's text mininghttps://conductscience.org/library/genes/4869NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42007444

GET https://conductscience.org/api/papers/v1/42007444/authors?page=2